* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download FRET Results Conclusions Introduction Protein Interaction
Phosphorylation wikipedia , lookup
Endomembrane system wikipedia , lookup
Hedgehog signaling pathway wikipedia , lookup
Protein (nutrient) wikipedia , lookup
Magnesium transporter wikipedia , lookup
Circular dichroism wikipedia , lookup
G protein–coupled receptor wikipedia , lookup
Protein phosphorylation wikipedia , lookup
Protein folding wikipedia , lookup
Protein moonlighting wikipedia , lookup
Green fluorescent protein wikipedia , lookup
Signal transduction wikipedia , lookup
Intrinsically disordered proteins wikipedia , lookup
Nuclear magnetic resonance spectroscopy of proteins wikipedia , lookup
List of types of proteins wikipedia , lookup
Bimolecular fluorescence complementation wikipedia , lookup
Proteolysis wikipedia , lookup
Fluorescence Resonance Energy Transfer (FRET) Studies of Protein Interaction Sarah F Martin*, Mike H Tatham, Ron T Hay and Ifor DW Samuel Biophotonics Collaboration, University of St Andrews FRET Results donor CFP acceptor YFP Figure 1: a) Absorption (---) and emission (__) spectra of CFP and YFP b) Schematic level diagram of FRET from CFP to YFP When fluorescently tagged proteins interact, the distance between the attached fluorescent probes is effectively reduced. This leads to energy transfer and related changes in the combined fluorescence spectra. direct excitation of YFP-Ubc9 100 control: CFP adding YFP-Ubc9 FRET signal: CFPSUMO adding YFPUbc9 0 420 440 460 480 500 520 540 wavelength [nm] 560 580 CFP YFP We report here in vitro FRET studies of protein binding, and show how they can be used to give quantitative results. While FRET is commonly detected visually and in vivo, we aim to develop quantitative and versatile screening assays. Figure 2: Ribbon diagram of tagged proteins showing FRET from CFP to YFP Increasing YFP-Ubc9: CFP-SUMO ratio from 0:1 to 7:1 Figures 3 and 4: Fluorescence microscopy photograph of CFP-SUMO in mouse cells (Rakel Fernandez) and schematic interactions of Ubc9, SUMO1 and RanGAP1 in human cells. 0.0 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 free YFP-Ubc9 [micromolar] 0.1 530nm 0 2 4 1 2.6 Analysis by deconvolution and single-exponential fit (IBH Das6 software) 2.4 0.1 475nm 0.01 6 8 10 12 14 time [ns] 2.2 2.0 0 2 4 475nm 1.8 0 1 2 3 4 5 6 7 YFP-Ubc9 / CFP-SUMO relative concentration 6 8 10 12 14 time [ns] 2 1 475nm 0 8 0 5 10 free YFP-Ubc9 [microM] 15 Figure 6. Time-resolved FRET measurements at 530nm and 475nm and binding curve with kd=0.6µM. A B C 5 170 4 a) Add Ubc9 to conjugate 2 3 4 5 6 83 62 CFPSUMO & YFPRanGAP1 130 b) Add SENP1 to deconjugate CFP-SUMO1 & YFP-RanGAP1 1 175 kDa 2 150 SENP1 Ubc9 0 47.5 6 1 110 100 200 300 time [min] 400 500 32.5 YFPRanGAP1 CFPSUMO Figure 7. Steady state FRET measurements and SDS electrophoresis gel of the conjugation of YFP-RanGAP1 to CFP-SUMO1 following the addition of Ubc9, and the deconjugation by SENP1. Protein Interaction In this work, we study the small ubiquitin-like modifier SUMO1 and its interactions with further proteins of the SUMO cycle, including enzymes (Ubc9), substrate (RanGAP1) and proteases (SENP1), which are important in many biological processes. Conventionally studied using NMR (see figure 3), and isothermal calorimetry (ITC) (see figure 4), FRET enables a very sensitive real-time examination of these molecular interactions. • SUMO1 and Ubc9 share one binding site. Their binding constant kd is estimated to be 0.25µM. Kd is defined for a reaction of the type A+B⇔AB as the product of the initial concentrations cA*cB divided by the concentration of the end product cAB, and is easily determined from the hyperbolic form of a binding curve displaying concentrations of bound versus free protein: Y = (Bmax x X) / (kd + X), where Bmax indicates the saturation of the reaction. We can fit this equation to experimental signals that indicate the amount of protein bound at varying ratios of two (or more) proteins, e.g. by adding increasing amounts of one component to the other. ITC will measure the heat change, and hence the total reaction taking place – with FRET, we can isolate information of specific interactions from within a complex manycomponent system at a much higher resolution. • Ubc9 catalyses the covalent linking of SUMO1 to RanGAP1, a substrate located at Human Cell the cell’s nuclear membrane. We can easily Ubc9 monitor the speed of this conjugation for Binds to SUMO: varying concentrations of Ubc9. noncovalent temporary • SENP1 cleaves 4 amino acids off the Nconnection RanGAP1 terminus of SUMO1, hence breaking its SENP1 Protease covalent link to RanGAP1. We can study this SUMO with both a tagged RanGAP1-SUMO1 nucleus Transfers SUMO1 to complex, or simply by tagging both ends of link to RanGAP1 on SUMO1. nuclear membrane 0.5 bound CFP-SUMO [microM] 1 FRET signal [au] SUMO Ubc9 1.0 600 3 50Ǻ 1.5 bound CFP-SUMO [micromolar] . intensity [au] 150 50 buffer CFP CFP-SUMO dilution of CFPSUMO Figure 5. Steady state FRET measurements of the binding of Ubc9 to SUMO1 (see also figure 2). a) A schematic overview of the experiment, b) spectra and c) the resulting binding curve with kd=0.6µM. 0.01 S0 200 lifetime [ns] S5 S4 S3 S2 S1 250 YFPUbc9 ln (nomralised photon count) S5 S4 S3 S2 S1 Complexes of CFP-SUMO, YFP-Ubc9 and YFP-RanGAP were expressed and purified. Steady-state and time-resolved experiments were performed taking into account dilution, direct excitation and non-specific interactions. The results are compiled in figures 5-7. CFP-SUMO Protein interactions regulate essential cellular functions, ranging from subcellular transport and cell structure formation to DNA transcription and translation to name just a few. Failure of the sophisticated cross-talk within complex protein cycles can lead to diseases such as Alzheimers, diabetes and certain forms of cancer. The study of these interactions has been significantly advanced by the discovery of the genetic structure of the green fluorescent protein (GFP) in the jellyfish Aequorea Victoria (1992), enabling fluorescent labelling. Furthermore, the introduction of mutations into GFP has allowed the generation of fluorescent probes with altered spectral properties (e.g. cyan CFP and yellow YFP), that facilitate the use of fluorescence resonance energy transfer (FRET) to indicate the proximity of tagged molecules. Energy transfer is observed as a decrease in emission 1 CFP intensity and fluorescence lifetime of a higher energy (bluer YFP “donor”), and an increase in emission and lifetime of a lower 0.5 energy (redder “acceptor”) fluorophore. For this dipoledipole coupling to occur, the emission spectrum of the donor 0 probe must overlap considerably the absorption spectrum of 350 400 450 500 550 600 wavelength [nm] the acceptor probe, which is the case for CFP and YFP (see figure 1a). Also, the two fluorophores must lie in close proximity (10100Ǻ). ln (nomralised photon count) absorbance / intensity [au] Introduction Conclusions • Fluorescence resonance energy transfer (FRET) is a powerful, versatile and sensitive tool and an exciting field of biophotonics research. • In this work we used SUMO1, Ubc9 and RanGAP1, proteins involved for example in subcellular transport within human cells, and the fluorescent proteins CFP and YFP that are a spectrally suitable FRET pair. •We demonstrate FRET between CFP-SUMO1 and YFP-Ubc9 arising from the binding of Ubc9 to SUMO1. This interaction clearly brings YFP and CFP into the proximity required for energy transfer, and the resulting FRET signal is proportional to the amount of protein bound. Not only can we confirm previous work on the binding of these two proteins, we can also quantitatively reproduce the associated binding constant kd with both steady-state and timeresolved experiments. • The Ubc9-catalysed conjugation of YFP-RanGAP to CFP-SUMO, and the subsequent cleaving of the complex were also monitored by FRET. This provides a real-time conjugation and protease cleaving assay, with a sensitivity and simplicity novel to biomolecular science. Conventional kinetics assays use gel electrophoresis – a more labour intensive method yielding results at both far lower resolution and sensitivity. • FRET requires no specific equipment beyond a fluorometer, gives a strong signal suitable for the analysis of small amounts of tagged protein, and reports only the information from specifically the tagged parts of a many-component experiment – making it ideal for the study of two proteins in the presence of further interacting enzymes. This, for the first time, enables the quantitative study of complex systems in vitro, and makes FRET an ideal high-throughput drug screening assay. • The versatility of this FRET-based technique is expected to yield fresh insight into the specificity of protein modification by SUMO and other ubiquitin-like proteins. Future work will explore the new possibilities available to studying protein interactions. Protein Structures from the RCSB Protein Data Bank at www.rcsb.org/pdb * School of Physics and Astronomy, North Haugh, St Andrews KY16 9SS [email protected]